New anti-inflammatory drug goes to FDA
(Reuters) UPDATED 2009-10-08
Drugmaker Nicox has submitted a new drug application to the U.S. Food and Drug Administration for its new anti-inflammatory medication Naproxcinod as a treatment for osteoarthritis. The company plans to the same in Europe in the last quarter of 2009.
Read full story >
See all Rheumatoid Arthritis News